Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.

Geng EH, Hare CB, Kahn JO, Jain V, Van Nunnery T, Christopoulos KA, Deeks SG, Gandhi M, Havlir DV.

Clin Infect Dis. 2012 Dec;55(12):1690-7. doi: 10.1093/cid/cis750. Epub 2012 Sep 5.

2.

Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.

Siegfried N, Uthman OA, Rutherford GW.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008272. doi: 10.1002/14651858.CD008272.pub2. Review.

PMID:
20238364
3.

Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.

Ying R, Barnabas RV, Williams BG.

Curr HIV/AIDS Rep. 2014 Dec;11(4):459-67. doi: 10.1007/s11904-014-0232-x. Review.

4.

Current status of HIV/AIDS in the ART era.

Yoshimura K.

J Infect Chemother. 2017 Jan;23(1):12-16. doi: 10.1016/j.jiac.2016.10.002. Epub 2016 Nov 5. Review.

PMID:
27825722
5.

CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Peeling RW, Sollis KA, Glover S, Crowe SM, Landay AL, Cheng B, Barnett D, Denny TN, Spira TJ, Stevens WS, Crowley S, Essajee S, Vitoria M, Ford N.

PLoS One. 2015 Mar 19;10(3):e0115019. doi: 10.1371/journal.pone.0115019. eCollection 2015. Review.

6.
7.

Twenty years of human immunodeficiency virus care at the Mayo Clinic: Past, present and future.

Cummins NW, Badley AD, Kasten MJ, Sampath R, Temesgen Z, Whitaker JA, Wilson JW, Yao JD, Zeuli J, Rizza SA.

World J Virol. 2016 May 12;5(2):63-7. doi: 10.5501/wjv.v5.i2.63. Review.

Supplemental Content

Support Center